Osteoarthritis: A disease of the joint as an organ

Arthritis and Rheumatism

Volumn 64, Issue 6, 2012, Pages 1697-1707

  Loeser, Richard F ^a   Goldring, Steven R ^b   Scanzello, Carla R ^c   Goldring, Mary B ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 2; COLLAGENASE 3; CYCLOOXYGENASE 2; INTERLEUKIN 1; STROMELYSIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ARTICULAR CARTILAGE; BONE; CARTILAGE CELL; HUMAN; JOINT; KNEE MENISCUS; LIGAMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNOVIUM;

CARTILAGE, ARTICULAR; HUMANS; INFLAMMATION; JOINTS; OSTEOARTHRITIS;

EID: 84861827675     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34453     Document Type: Review

References (100)

1. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation-United States, 2007-2009. MMWR Morb Mortal Wkly Rep 2010; 59: 1261-5.
2. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000; 133: 635-46.
3. Blagojevic M, Jinks C, Jeffery A, Jordan KP,. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 2010; 18: 24-33.
4. Greene GW, Banquy X, Lee DW, Lowrey DD, Yu J, Israelachvili JN,. Adaptive mechanically controlled lubrication mechanism found in articular joints. Proc Natl Acad Sci U S A 2011; 108: 5255-9.
5. Andriacchi TP, Mundermann A, Smith RL, Alexander EJ, Dyrby CO, Koo S,. A framework for the in vivo pathomechanics of osteoarthritis at the knee. Ann Biomed Eng 2004; 32: 447-57.
6. Goldring MB, Marcu KB,. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 2009; 11: 224.
7. Troeberg L, Nagase H,. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim Biophys Acta 2012; 1824: 133-45.
8. Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005; 434: 644-8.
9. Little CB, Barai A, Burkhardt D, Smith SM, Fosang AJ, Werb Z, et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 2009; 60: 3723-33.
10. Polur I, Lee PL, Servais JM, Xu L, Li Y,. Role of HTRA1, a serine protease, in the progression of articular cartilage degeneration. Histol Histopathol 2010; 25: 599-608.
11. Xu L, Servais J, Polur I, Kim D, Lee PL, Chung K, et al. Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. Arthritis Rheum 2010; 62: 2736-44.
12. Echtermeyer F, Bertrand J, Dreier R, Meinecke I, Neugebauer K, Fuerst M, et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 2009; 15: 1072-6.
13. Yang S, Kim J, Ryu JH, Oh H, Chun CH, Kim BJ, et al. Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010; 16: 687-93.
14. Tetsunaga T, Nishida K, Furumatsu T, Naruse K, Hirohata S, Yoshida A, et al. Regulation of mechanical stress-induced MMP-13 and ADAMTS-5 expression by RUNX-2 transcriptional factor in SW1353 chondrocyte-like cells. Osteoarthritis Cartilage 2011; 19: 222-32.
15. Hashimoto K, Oreffo RO, Gibson MB, Goldring MB, Roach HI,. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum 2009; 60: 3303-13.
16. Dudek KA, Lafont JE, Martinez-Sanchez A, Murphy CL,. Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes. J Biol Chem 2010; 285: 24381-7.
17. Miyaki S, Sato T, Inoue A, Otsuki S, Ito Y, Yokoyama S, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010; 24: 1173-85.
18. Geurts J, van den Brand BT, Wolf A, Abdollahi-Roodsaz S, Arntz OJ, Kracht M, et al. Toll-like receptor 4 signalling is specifically TGF-β-activated kinase 1 independent in synovial fibroblasts. Rheumatology (Oxford) 2011; 50: 1216-25.
19. Liu-Bryan R, Terkeltaub R,. Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum 2010; 62: 2004-12.
20. Heinola T, Kouri VP, Clarijs P, Ciferska H, Sukura A, Salo J, et al. High mobility group box-1 (HMGB-1) in osteoarthritic cartilage. Clin Exp Rheumatol 2010; 28: 511-8.
21. Garcia-Arnandis I, Guillen MI, Gomar F, Pelletier JP, Martel-Pelletier J, Alcaraz MJ,. High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthritis Res Ther 2010; 12: R165.
22. Yammani RR, Carlson CS, Bresnick AR, Loeser RF,. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum 2006; 54: 2901-11.
23. Zreiqat H, Belluoccio D, Smith MM, Wilson R, Rowley LA, Jones K, et al. S100A8 and S100A9 in experimental osteoarthritis. Arthritis Res Ther 2010; 12: R16.
24. Blanco FJ, Rego I, Ruiz-Romero C,. The role of mitochondria in osteoarthritis. Nat Rev Rheumatol 2011; 7: 161-9.
25. Luyten FP, Tylzanowski P, Lories RJ,. Wnt signaling and osteoarthritis. Bone 2009; 44: 522-7.
26. Blom AB, Brockbank SM, van Lent PL, van Beuningen HM, Geurts J, Takahashi N, et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum 2009; 60: 501-12.
27. Homandberg GA, Wen C, Hui F,. Cartilage damaging activities of fibronectin fragments derived from cartilage and synovial fluid. Osteoarthritis Cartilage 1998; 6: 231-44.
28. Zack MD, Arner EC, Anglin CP, Alston JT, Malfait AM, Tortorella MD,. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage. Arthritis Rheum 2006; 54: 2912-22.
29. Melrose J, Fuller ES, Roughley PJ, Smith MM, Kerr B, Hughes CE, et al. Fragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissues. Arthritis Res Ther 2008; 10: R79.
30. Bank RA, Krikken M, Beekman B, Stoop R, Maroudas A, Lafeber FP, et al. A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 1997; 16: 233-43.
31. Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hegde PS, et al. NF-κB mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 2005; 174: 5781-8.
32. Fichter M, Korner U, Schomburg J, Jennings L, Cole AA, Mollenhauer J,. Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes. J Orthop Res 2006; 24: 63-70.
33. Heinegard D, Saxne T,. The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 2011; 7: 50-6.
34. Happonen KE, Saxne T, Aspberg A, Morgelin M, Heinegard D, Blom AM,. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum 2010; 62: 3574-83.
35. Loeser RF,. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage 2009; 17: 971-9.
36. Taniguchi N, Carames B, Ronfani L, Ulmer U, Komiya S, Bianchi ME, et al. Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis. Proc Natl Acad Sci U S A 2009; 106: 1181-6.
37. Del Carlo M Jr, Loeser RF,. Cell death in osteoarthritis. Curr Rheumatol Rep 2008; 10: 37-42.
38. Carames B, Taniguchi N, Otsuki S, Blanco FJ, Lotz M,. Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum 2010; 62: 791-801.
39. D'Lima D, Hermida J, Hashimoto S, Colwell C, Lotz M,. Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. Arthritis Rheum 2006; 54: 1814-21.
40. Ea HK, Nguyen C, Bazin D, Bianchi A, Guicheux J, Reboul P, et al. Articular cartilage calcification in osteoarthritis: insights into crystal-induced stress [review]. Arthritis Rheum 2011; 63: 10-8.
41. Musacchio E, Ramonda R, Perissinotto E, Sartori L, Hirsch R, Punzi L, et al. The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA Study from northeastern Italy. Ann Rheum Dis 2011; 70: 1937-43.
42. Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R,. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 2005; 174: 5016-23.
43. Jin C, Frayssinet P, Pelker R, Cwirka D, Hu B, Vignery A, et al. NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite- associated arthropathy. Proc Natl Acad Sci U S A 2011; 108: 14867-72.
44. Englund M, Guermazi A, Gale D, Hunter DJ, Aliabadi P, Clancy M, et al. Incidental meniscal findings on knee MRI in middle-aged and elderly persons. N Engl J Med 2008; 359: 1108-15.
45. Englund M, Guermazi A, Roemer FW, Aliabadi P, Yang M, Lewis CE, et al. Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle-aged and elderly persons: the Multicenter Osteoarthritis Study. Arthritis Rheum 2009; 60: 831-9.
46. Hill CL, Seo GS, Gale D, Totterman S, Gale ME, Felson DT,. Cruciate ligament integrity in osteoarthritis of the knee. Arthritis Rheum 2005; 52: 794-9.
47. Katsuragawa Y, Saitoh K, Tanaka N, Wake M, Ikeda Y, Furukawa H, et al. Changes of human menisci in osteoarthritic knee joints. Osteoarthritis Cartilage 2010; 18: 1133-43.
48. Pauli C, Grogan SP, Patil S, Otsuki S, Hasegawa A, Koziol J, et al. Macroscopic and histopathologic analysis of human knee menisci in aging and osteoarthritis. Osteoarthritis Cartilage 2011; 19: 1132-41.
49. Ashraf S, Wibberley H, Mapp PI, Hill R, Wilson D, Walsh DA,. Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis. Ann Rheum Dis 2011; 70: 523-9.
50. Sharma L, Lou C, Felson DT, Dunlop DD, Kirwan-Mellis G, Hayes KW, et al. Laxity in healthy and osteoarthritic knees. Arthritis Rheum 1999; 42: 861-70.
51. Watanabe A, Kanamori A, Ikeda K, Ochiai N,. Histological evaluation and comparison of the anteromedial and posterolateral bundle of the human anterior cruciate ligament of the osteoarthritic knee joint. Knee 2011; 18: 47-50.
52. Mullaji AB, Marawar SV, Simha M, Jindal G,. Cruciate ligaments in arthritic knees: a histologic study with radiologic correlation. J Arthroplasty 2008; 23: 567-72.
53. Hasegawa A, Otsuki S, Pauli C, Miyaki S, Patil S, Steklov N, et al. Anterior cruciate ligament changes in human joint in aging and osteoarthritis. Arthritis Rheum 2012; 64: 696-704.
54. Frost HM,. Genetic and hormonal roles in bone disorders: insights of an updated bone physiology. J Musculoskelet Neuronal Interact 2003; 3: 118-35.
55. Taljanovic MS, Graham AR, Benjamin JB, Gmitro AF, Krupinski EA, Schwartz SA, et al. Bone marrow edema pattern in advanced hip osteoarthritis: quantitative assessment with magnetic resonance imaging and correlation with clinical examination, radiographic findings, and histopathology. Skeletal Radiol 2008; 37: 423-31.
56. Van der Kraan PM, van den Berg WB,. Osteophytes: relevance and biology. Osteoarthritis Cartilage 2007; 15: 237-44.
57. Zoricic S, Maric I, Bobinac D, Vukicevic S,. Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. J Anat 2003; 202: 269-77.
58. Blaney Davidson EN, van der Kraan PM, van den Berg WB,. TGF-β and osteoarthritis. Osteoarthritis Cartilage 2007; 15: 597-604.
59. Walsh DA, Bonnet CS, Turner EL, Wilson D, Situ M, McWilliams DF,. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage 2007; 15: 743-51.
60. Walsh DA, McWilliams DF, Turley MJ, Dixon MR, Franses RE, Mapp PI, et al. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) 2010; 49: 1852-61.
61. Ashraf S, Mapp PI, Walsh DA,. Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis. Arthritis Rheum 2011; 63: 2700-10.
62. Donnelly E, Chen DX, Boskey AL, Baker SP, van der Meulen MC,. Contribution of mineral to bone structural behavior and tissue mechanical properties. Calcif Tissue Int 2010; 87: 450-60.
63. Day JS, Ding M, van der Linden JC, Hvid I, Sumner DR, Weinans H,. A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage. J Orthop Res 2001; 19: 914-8.
64. Goldring MB, Goldring SR,. Osteoarthritis. J Cell Physiol 2007; 213: 626-34.
65. Karvonen RL, Miller PR, Nelson DA, Granda JL, Fernandez-Madrid F,. Periarticular osteoporosis in osteoarthritis of the knee. J Rheumatol 1998; 25: 2187-94.
66. Messent EA, Ward RJ, Tonkin CJ, Buckland-Wright C,. Tibial cancellous bone changes in patients with knee osteoarthritis: a short-term longitudinal study using Fractal Signature Analysis. Osteoarthritis Cartilage 2005; 13: 463-70.
67. Messent EA, Buckland-Wright JC, Blake GM,. Fractal analysis of trabecular bone in knee osteoarthritis (OA) is a more sensitive marker of disease status than bone mineral density (BMD). Calcif Tissue Int 2005; 76: 419-25.
68. Chan BY, Fuller ES, Russell AK, Smith SM, Smith MM, Jackson MT, et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage 2011; 19: 874-85.
69. Bingham CO III, Buckland-Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational Knee Osteoarthritis Structural Arthritis study. Arthritis Rheum 2006; 54: 3494-507.
70. Pessler F, Dai L, Diaz-Torne C, Gomez-Vaquero C, Paessler ME, Zheng DH, et al. The synovitis of "non-inflammatory" orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis. Ann Rheum Dis 2008; 67: 1184-7.
71. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B,. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005; 64: 1263-7.
72. Scanzello CR, McKeon B, Swaim BH, DiCarlo E, Asomugha EU, Kanda V, et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum 2011; 63: 391-400.
73. Krasnokutsky S, Belitskaya-Levy I, Bencardino J, Samuels J, Attur M, Regatte R, et al. Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum 2011; 63: 2983-91.
74. Pearle AD, Scanzello CR, George S, Mandl LA, DiCarlo EF, Peterson M, et al. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis Cartilage 2007; 15: 516-23.
75. Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M,. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis-results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 2005; 13: 361-7.
76. Hill CL, Hunter DJ, Niu J, Clancy M, Guermazi A, Genant H, et al. Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis 2007; 66: 1599-603.
77. Roemer FW, Guermazi A, Felson DT, Niu J, Nevitt MC, Crema MD, et al. Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study. Ann Rheum Dis 2011; 70: 1804-9.
78. Conaghan PG, D'Agostino MA, Le Bars M, Baron G, Schmidely N, Wakefield R, et al. Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study. Ann Rheum Dis 2010; 69: 644-7.
79. Torres L, Dunlop DD, Peterfy C, Guermazi A, Prasad P, Hayes KW, et al. The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage 2006; 14: 1033-40.
80. Sowers M, Karvonen-Gutierrez CA, Jacobson JA, Jiang Y, Yosef M,. Associations of anatomical measures from MRI with radiographically defined knee osteoarthritis score, pain, and physical functioning. J Bone Joint Surg Am 2011; 93: 241-51.
81. Cohen SB, Proudman S, Kivitz AJ, Burch FX, Donohue JP, Burstein D, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011; 13: R125.
82. Magnano MD, Chakravarty EF, Broudy C, Chung L, Kelman A, Hillygus J, et al. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol 2007; 34: 1323-7.
83. Ling SM, Patel DD, Garnero P, Zhan M, Vaduganathan M, Muller D, et al. Serum protein signatures detect early radiographic osteoarthritis. Osteoarthritis Cartilage 2009; 17: 43-8.
84. Scanzello CR, Umoh E, Pessler F, Diaz-Torne C, Miles T, Dicarlo E, et al. Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage 2009; 17: 1040-8.
85. Honorati MC, Bovara M, Cattini L, Piacentini A, Facchini A,. Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis. Osteoarthritis Cartilage 2002; 10: 799-807.
86. Chen L, Li DQ, Zhong J, Wu XL, Chen Q, Peng H, et al. IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis. Osteoarthritis Cartilage 2011; 19: 711-8.
87. Endres M, Andreas K, Kalwitz G, Freymann U, Neumann K, Ringe J, et al. Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Osteoarthritis Cartilage 2010; 18: 1458-66.
88. Cuellar JM, Scuderi GJ, Cuellar VG, Golish SR, Yeomans DC,. Diagnostic utility of cytokine biomarkers in the evaluation of acute knee pain. J Bone Joint Surg Am 2009; 91: 2313-20.
89. Miller RJ, Banisadr G, Bhattacharyya BJ,. CXCR4 signaling in the regulation of stem cell migration and development. J Neuroimmunol 2008; 198: 31-8.
90. Akira S, Takeda K,. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
91. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 2009; 15: 774-80.
92. Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M,. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 1997; 56: 299-307.
93. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008; 118: 205-16.
94. Sjoberg A, Onnerfjord P, Morgelin M, Heinegard D, Blom AM,. The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem 2005; 280: 32301-8.
95. Kalchishkova N, Furst CM, Heinegard D, Blom AM,. NC4 domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H. J Biol Chem 2011; 286: 27915-26.
96. Konttinen YT, Ceponis A, Meri S, Vuorikoski A, Kortekangas P, Sorsa T, et al. Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane. Ann Rheum Dis 1996; 55: 888-94.
97. Gobezie R, Kho A, Krastins B, Sarracino DA, Thornhill TS, Chase M, et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007; 9: R36.
98. Rosenthal AK, Gohr CM, Ninomiya J, Wakim BT,. Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage. Arthritis Rheum 2011; 63: 401-11.
99. Wang Q, Rozelle A, Lepus C, Scanzello C, Song J, Larsen D, et al. Identification of a central role for complement in osteoarthritis. Nature Medicine 2011; 17: 1674-9.
100. McGonagle D, Tan AL, Carey J, Benjamin M,. The anatomical basis for a novel classification of osteoarthritis and allied disorders. J Anat 2010; 216: 279-91.